The WHO-endorsed one-dose HPV vaccination schedule — the single-dose regimen for girls aged 9–14 replacing the traditional two- or three-dose series, dramatically reducing program costs and logistical complexity while maintaining protective efficacy — represents the fastest-transforming policy driver in the global HPV vaccine landscape, with the Human Papillomavirus Vaccine...